Spyre Therapeutics Aktie
WKN DE: A3D4LY / ISIN: US00773J2024
14.10.2025 20:17:34
|
Spyre Therapeutics Stock Rises 11% After $275 Mln Public Offering Pricing
(RTTNews) - Spyre Therapeutics, Inc. (SYRE) rose 11.31% to $21.06, up $2.14, following the announcement of a $275 million public offering of common stock at $18.50 per share.
The stock opened at $19.15, hit a high of $21.41 and a low of $18.30, versus a previous close of $18.92. It trades on the NASDAQ, with a volume of 2.87 million shares, sharply above its average.
The 52-week range is $12.10 to $21.41.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Spyre Therapeuticsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Spyre Therapeuticsmehr Analysen
Aktien in diesem Artikel
Spyre Therapeutics | 17,80 | 11,25% |
|